Treprostinil Iv Suppliers & Bulk Manufacturers
Available Forms: SC or Intravenous (IV)
Available Strengths: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)
Reference Brands: Remodulin(US & EU)
Category: Orphan Drugs
Treprostinil, administered via subcutaneous or intravenous infusion, is a prostacyclin analogue that dilates pulmonary blood vessels and inhibits platelet aggregation. It improves exercise capacity, reduces PAH symptoms, and enhances quality of life by lowering pulmonary arterial pressure and decreasing vascular resistance in patients with pulmonary arterial hypertension.
Product Description:
Treprostinil, marketed as Remodulin®, is approved in the US and EU for pulmonary arterial hypertension (PAH). Regulatory dossiers include comprehensive clinical data, manufacturing standards, and safety profiles submitted to FDA and EMA, supporting its approval for subcutaneous and intravenous use. The product is used for continuous infusion to improve exercise capacity and reduce symptoms. Dossiers demonstrate high-quality manufacturing and proven efficacy. For detailed insights on regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory updates and industry insights.
Treprostinil Iv — third party manufacturing & bulk supply
Treprostinil Iv is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Treprostinil Iv is supplied as SC or Intravenous (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Treprostinil Iv listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Treprostinil Iv →Frequently Asked Questions
Treprostinil is used to treat pulmonary arterial hypertension (PAH). It helps improve exercise ability and reduces symptoms by relaxing and widening the blood vessels in the lungs, allowing blood to flow more easily.
Treprostinil is a synthetic analogue of prostacyclin, a naturally occurring substance in the body that helps dilate blood vessels and inhibit platelet aggregation.
Well-known trade names of treprostinil include Remodulin, Tyvaso, and Orenitram, depending on the dosage form and region.
The original brands were developed and marketed by United Therapeutics, and generic versions are now manufactured by several pharmaceutical companies in different countries.
The generic name of the medicine is treprostinil.
The main brand names are Remodulin, Tyvaso, and Orenitram.
Treprostinil products are manufactured in multiple countries including the United States, European countries, India, and other regions where approved pharmaceutical manufacturers produce the drug for global markets.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
